| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1312143 | 6480464 | Ethinyl Estradiol results in increased expression of AGR2 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1304606 | 6480464 | Ethinyl Estradiol results in increased expression of AGR2 mRNA | CTD | PMID:17557909 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1312143 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AGR2 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Estradiol promotes the reaction [ESR1 protein binds to AGR2 promoter]; more ... | CTD | PMID:20531310 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of AGR2 mRNA | CTD | PMID:23019147 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of AGR2 mRNA | CTD | PMID:16474171 PMID:21185374 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of AGR2 mRNA | CTD | PMID:16474171 more ... |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Estradiol promotes the reaction [[ESR1 protein binds to AGR2 promoter] which results in increased expression of AGR2 mRNA] | CTD | PMID:20531310 PMID:20531310 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of AGR2 protein | CTD | PMID:20531310 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of AGR2 mRNA | CTD | PMID:16474171 |
| 17beta-hydroxy-5alpha-androstan-3-one | affects expression | EXP | | 6480464 | Dihydrotestosterone affects the expression of AGR2 mRNA | CTD | PMID:17094431 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of AGR2 protein]; more ... | CTD | PMID:20299546 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of AGR2 mRNA | CTD | PMID:18061397 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of AGR2 mRNA | CTD | PMID:20106945 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of AGR2 mRNA | CTD | PMID:18061397 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of AGR2 mRNA | CTD | PMID:20106945 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1312143 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AGR2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of AGR2 protein | CTD | PMID:20299546 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of AGR2 mRNA | CTD | PMID:18061397 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:1312143 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of AGR2 mRNA | CTD | PMID:17982090 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AGR2 mRNA | CTD | PMID:16997883 |
| 3-methylcholanthrene | multiple interactions | EXP | | 6480464 | Methylcholanthrene promotes the reaction [AHR protein binds to AGR2 promoter] | CTD | PMID:20348232 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | TP53 protein affects the reaction [Fluorouracil results in decreased expression of AGR2 mRNA] | CTD | PMID:15016801 |
| 6-propyl-2-thiouracil | decreases expression | ISO | RGD:1304606 | 6480464 | Propylthiouracil results in decreased expression of AGR2 mRNA | CTD | PMID:22504374 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AGR2 mRNA | CTD | PMID:16997883 |
| arsenite(3-) | increases expression | ISO | RGD:1312143 | 6480464 | arsenite results in increased expression of AGR2 mRNA | CTD | PMID:18991936 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of AGR2 mRNA | CTD | PMID:18061397 more ... |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of AGR2 mRNA | CTD | PMID:18061397 more ... |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of AGR2 mRNA | CTD | PMID:18061397 more ... |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of AGR2 mRNA | CTD | PMID:20106945 more ... |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of AGR2 mRNA | CTD | PMID:21871943 more ... |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of AGR2 mRNA | CTD | PMID:20106945 PMID:18061397 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of AGR2 protein | CTD | PMID:20299546 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of AGR2 mRNA | CTD | PMID:18061397 PMID:20106945 |
| bicalutamide | increases expression | EXP | | 6480464 | bicalutamide results in increased expression of AGR2 mRNA | CTD | PMID:15638997 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of AGR2 mRNA | CTD | PMID:16474171 |
| calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of AGR2 mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of AGR2 mRNA | CTD | PMID:21592394 |
| capecitabine | increases response to substance | EXP | | 6480464 | AGR2 protein results in increased susceptibility to capecitabine | CTD | PMID:16734730 |
| chloroprene | increases expression | ISO | RGD:1312143 | 6480464 | Chloroprene results in increased expression of AGR2 mRNA | CTD | PMID:23125180 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of AGR2 mRNA | CTD | PMID:19376846 |
| coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR2 mRNA; more ... | CTD | PMID:19167446 |
| coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of AGR2 mRNA | CTD | PMID:19167446 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of AGR2 mRNA | CTD | PMID:17198877 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of AGR2 mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of AGR2 mRNA | CTD | PMID:20106945 PMID:21632981 |
| dehydroepiandrosterone | affects expression | EXP | | 6480464 | Dehydroepiandrosterone affects the expression of AGR2 mRNA | CTD | PMID:17094431 |
| dexamethasone | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AGR2 mRNA | CTD | PMID:16997883 |
| diarsenic trioxide | decreases response to substance | EXP | | 6480464 | AGR2 protein results in decreased susceptibility to arsenic trioxide | CTD | PMID:20707922 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of AGR2 mRNA | CTD | PMID:22521957 |
| diethylstilbestrol | multiple interactions | ISO | RGD:1312143 | 6480464 | [sodium arsenite co-treated with Diethylstilbestrol] results in increased expression of AGR2 mRNA | CTD | PMID:19665456 |
| disodium selenite | decreases expression | EXP | | 6480464 | Sodium Selenite results in decreased expression of AGR2 mRNA | CTD | PMID:18175754 |
| folic acid | increases expression | EXP | | 6480464 | Folic Acid results in increased expression of AGR2 mRNA | CTD | PMID:17868486 |
| fulvestrant | affects response to substance | EXP | | 6480464 | AGR2 protein affects the susceptibility to fulvestrant | CTD | PMID:20525379 |
| genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of AGR2 mRNA | CTD | PMID:16474171 |
| hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of AGR2 mRNA | CTD | PMID:20044591 |
| isotretinoin | decreases expression | EXP | | 6480464 | Isotretinoin results in decreased expression of AGR2 mRNA | CTD | PMID:20436886 |
| menadione | affects expression | EXP | | 6480464 | Vitamin K 3 affects the expression of AGR2 mRNA | CTD | PMID:20044591 |
| methimazole | decreases expression | ISO | RGD:1304606 | 6480464 | Methimazole results in decreased expression of AGR2 mRNA | CTD | PMID:22504374 |
| pirinixic acid | decreases expression | ISO | RGD:1312143 | 6480464 | pirinixic acid results in decreased expression of AGR2 mRNA | CTD | PMID:17426115 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of AGR2 mRNA | CTD | PMID:21632981 |
| resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of AGR2 mRNA | CTD | PMID:19167446 |
| tamoxifen | multiple interactions | EXP | | 6480464 | Tamoxifen promotes the reaction [ESR1 protein binds to AGR2 promoter]; more ... | CTD | PMID:20531310 |
| tamoxifen | multiple interactions | EXP | | 6480464 | Tamoxifen promotes the reaction [[ESR1 protein binds to AGR2 promoter] which results in increased expression of AGR2 mRNA] | CTD | PMID:20531310 PMID:20531310 |
| tamoxifen | affects response to substance | EXP | | 6480464 | AGR2 protein affects the susceptibility to Tamoxifen | CTD | PMID:20525379 |
| tamoxifen | decreases response to substance | EXP | | 6480464 | AGR2 protein results in decreased susceptibility to Tamoxifen | CTD | PMID:20531310 |
| tamoxifen | increases expression | EXP | | 6480464 | Tamoxifen results in increased expression of AGR2 mRNA; more ... | CTD | PMID:20531310 |
| testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of AGR2 mRNA | CTD | PMID:21592394 |
| testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of AGR2 mRNA | CTD | PMID:21592394 |
| testosterone | affects expression | ISO | RGD:1312143 | 6480464 | Testosterone affects the expression of AGR2 mRNA | CTD | PMID:17003280 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of AGR2 mRNA | CTD | PMID:19167446 |
| zinc atom | increases expression | ISO | RGD:1312143 | 6480464 | Zinc deficiency results in increased expression of AGR2 mRNA | CTD | PMID:20857495 |
| zinc(0) | increases expression | ISO | RGD:1312143 | 6480464 | Zinc deficiency results in increased expression of AGR2 mRNA | CTD | PMID:20857495 |